1. 球脊髄性筋萎縮症 Spinal and bulbar muscular atrophy Clinical trials / Disease details
臨床試験数 : 17 / 薬物数 : 16 - (DrugBank : 8) / 標的遺伝子数 : 10 - 標的パスウェイ数 : 17
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00851461 (ClinicalTrials.gov) | April 2008 | 25/2/2009 | Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy | Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy in Thai Patients | Spinobulbar Muscular Atrophy;Kennedy's Disease | Drug: Goserelin;Procedure: Electrophysiologic study;Procedure: tissue biopsy | Ramathibodi Hospital | AstraZeneca | Completed | 20 Years | N/A | Male | 10 | Phase 4 | Thailand |